Compounding for Pain Management – Survey | June 2024 Seminar

SEMINAR SURVEY
PERSONALIZED ANALGESIC THERAPY: TARGETING PAIN AT ITS SOURCE
JUNE 8-9, 2024, TORONTO

THANK YOU FOR ACCEPTING TO TAKE PART IN LP3 NETWORK’S SURVEY ON COMPOUNDING FOR PAIN MANAGEMENT.

This quick 5-question survey seeks to capture your experience and insights with LP3 Network’s pain management program, Personalized Analgesic Therapy: Targeting Pain at its Source.

Completion of this survey will help improve the quality of this program and other future pain-related learning initiatives to foster growth in your compounding practices for pain management.

Your response is sincerely appreciated.

Please note: A red asterisk (*) indicates that a response is required.

Where is your primary practice? *

If you're outside of the USA & Canada or for unique situations (multiple states/provinces, cross-border, etc.) please use the "Other" option to specify.

USA

Canada

Other...

Where is your primary practice? Other...

State/Province *

Please choose your profession: *

Pharmacist

Pharmacy Technician

Physician

Other

Please choose your profession: Other

Please indicate whether the following topics were sufficiently covered to enhance your knowledge in compounding for pain management. *

	Amount of information was just right	More information was needed	Too much information was provided
Challenges in pain management / re-evaluating pain management	Challenges in pain management / re-evaluating pain management - Amount of information was just right	Challenges in pain management / re-evaluating pain management - More information was needed	Challenges in pain management / re-evaluating pain management - Too much information was provided
Personalized pain management principles	Personalized pain management principles - Amount of information was just right	Personalized pain management principles - More information was needed	Personalized pain management principles - Too much information was provided
Classification of pain (e.g., nociceptive inflammatory, neuropathic)	Classification of pain (e.g., nociceptive inflammatory, neuropathic) - Amount of information was just right	Classification of pain (e.g., nociceptive inflammatory, neuropathic) - More information was needed	Classification of pain (e.g., nociceptive inflammatory, neuropathic) - Too much information was provided
Pain signaling cascade	Pain signaling cascade - Amount of information was just right	Pain signaling cascade - More information was needed	Pain signaling cascade - Too much information was provided
Chronic pain (role of central sensitization)	Chronic pain (role of central sensitization) - Amount of information was just right	Chronic pain (role of central sensitization) - More information was needed	Chronic pain (role of central sensitization) - Too much information was provided
Analgesic pharmacology for ~50 drugs (pharmacodynamics, efficacy/safety for topical administration)	Analgesic pharmacology for ~50 drugs (pharmacodynamics, efficacy/safety for topical administration) - Amount of information was just right	Analgesic pharmacology for ~50 drugs (pharmacodynamics, efficacy/safety for topical administration) - More information was needed	Analgesic pharmacology for ~50 drugs (pharmacodynamics, efficacy/safety for topical administration) - Too much information was provided
Compounding considerations for topical delivery	Compounding considerations for topical delivery - Amount of information was just right	Compounding considerations for topical delivery - More information was needed	Compounding considerations for topical delivery - Too much information was provided
Compounding considerations for transdermal delivery	Compounding considerations for transdermal delivery - Amount of information was just right	Compounding considerations for transdermal delivery - More information was needed	Compounding considerations for transdermal delivery - Too much information was provided
Compounding considerations for transmucosal delivery	Compounding considerations for transmucosal delivery - Amount of information was just right	Compounding considerations for transmucosal delivery - More information was needed	Compounding considerations for transmucosal delivery - Too much information was provided

Please share any further comments you may have about the topics presented in this program.

Please indicate whether the following pain conditions and respective case studies were sufficiently covered to help enhance your practice in compounding for pain management. *

	Amount of information was just right	More information was needed	Too much information was provided
Knee osteoarthritis	Knee osteoarthritis - Amount of information was just right	Knee osteoarthritis - More information was needed	Knee osteoarthritis - Too much information was provided
Chronic back pain	Chronic back pain - Amount of information was just right	Chronic back pain - More information was needed	Chronic back pain - Too much information was provided
Anal fissures	Anal fissures - Amount of information was just right	Anal fissures - More information was needed	Anal fissures - Too much information was provided
Fibromyalgia	Fibromyalgia - Amount of information was just right	Fibromyalgia - More information was needed	Fibromyalgia - Too much information was provided
Diabetic neuropathy	Diabetic neuropathy - Amount of information was just right	Diabetic neuropathy - More information was needed	Diabetic neuropathy - Too much information was provided
Post-surgical pain – preventing addiction	Post-surgical pain – preventing addiction - Amount of information was just right	Post-surgical pain – preventing addiction - More information was needed	Post-surgical pain – preventing addiction - Too much information was provided
Opioid use disorder	Opioid use disorder - Amount of information was just right	Opioid use disorder - More information was needed	Opioid use disorder - Too much information was provided

Please share any further comments you may have about the pain conditions/cases presented in this program.

Please Indicate Whether the Following Aspects of the Program Were Constructive to Your Overall Learning Experience *

	Constructive	Neutral	Not Overly Constructive
Small group activities	Small group activities - Constructive	Small group activities - Neutral	Small group activities - Not Overly Constructive
Group activity workbook to complete during seminar	Group activity workbook to complete during seminar - Constructive	Group activity workbook to complete during seminar - Neutral	Group activity workbook to complete during seminar - Not Overly Constructive
Poll questions	Poll questions - Constructive	Poll questions - Neutral	Poll questions - Not Overly Constructive
Facilitator-led discussions	Facilitator-led discussions - Constructive	Facilitator-led discussions - Neutral	Facilitator-led discussions - Not Overly Constructive
Amount of slide content	Amount of slide content - Constructive	Amount of slide content - Neutral	Amount of slide content - Not Overly Constructive
Number of topics covered	Number of topics covered - Constructive	Number of topics covered - Neutral	Number of topics covered - Not Overly Constructive
In-person format of seminar	In-person format of seminar - Constructive	In-person format of seminar - Neutral	In-person format of seminar - Not Overly Constructive
Seminar pre-read material	Seminar pre-read material - Constructive	Seminar pre-read material - Neutral	Seminar pre-read material - Not Overly Constructive

Are there any active ingredients (single or in combination) that you would like to see covered in future programs? *

Yes

No

Please specify: *

Please share other topics that you felt should have been covered / any final comments you may have that could help improve this program.

LP3 Network Education

Compounding for Pain Management – Survey | June 2024 Seminar

SEMINAR SURVEY
PERSONALIZED ANALGESIC THERAPY: TARGETING PAIN AT ITS SOURCE
JUNE 8-9, 2024, TORONTO

THANK YOU FOR ACCEPTING TO TAKE PART IN LP3 NETWORK’S SURVEY ON COMPOUNDING FOR PAIN MANAGEMENT.

Thank you for taking the time to complete this survey.

You are here

Compounding for Pain Management – Survey | June 2024 Seminar

SEMINAR SURVEYPERSONALIZED ANALGESIC THERAPY: TARGETING PAIN AT ITS SOURCE JUNE 8-9, 2024, TORONTO

THANK YOU FOR ACCEPTING TO TAKE PART IN LP3 NETWORK’S SURVEY ON COMPOUNDING FOR PAIN MANAGEMENT.

Thank you for taking the time to complete this survey.

SEMINAR SURVEY
PERSONALIZED ANALGESIC THERAPY: TARGETING PAIN AT ITS SOURCE
JUNE 8-9, 2024, TORONTO